You are here

Article Text

Article menu

other Versions

Download PDFPDF
Review
2022 Society of Gynecologic Oncology meeting report
  1. Dimitrios Nasioudis1 and
  2. Pedro T Ramirez2
  1. 1Obstetrics and Gynecology, Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania, USA
  2. 2Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA
  1. Correspondence to Dr Dimitrios Nasioudis, Obstetrics and Gynecology, Hospital of the University of Pennsylvania, Philadelphia, PA 19104, USA; dimitrios.nasioudis{at}pennmedicine.upenn.edu

Abstract

The Society of Gynecologic Oncology (SGO) 2022 Annual Meeting was held between 18-21 March in Phoenix, Arizona. Multiple scientific plenary sessions covered key research concepts that included novel therapeutics, precision oncology, clinical trials, cancer care delivery, diversity, equity and inclusion, surgical trials and translational research. In the present report presentations that may impact clinical care are summarized.

  • Uterine Cancer
  • Ovarian Cancer
  • Cervical Cancer

https://doi.org/10.1136/ijgc-2022-003672

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    View Full Text

    Footnotes

    • Twitter @pedroramirezMD

    • Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.

    • Competing interests None declared.

    • Provenance and peer review Commissioned; internally peer reviewed.